Target intelligence / Profile preview

Diseased cells

Molecular classification
Other
01

Overview

The term 'Diseased cells' refers to a broad biological state or a population of cells undergoing pathological changes, rather than a specific molecular target like a receptor, enzyme, or transporter. In the context of pharmacology and drug discovery, a therapeutic target is defined as a specific molecule—typically a protein—whose activity can be modulated by a medicinal agent to achieve a desired therapeutic outcome [8]. While diseased cells are the intended site of action for many therapies, the actual drug interaction occurs at the molecular level with components such as cell-surface antigens or intracellular signaling proteins [3, 10]. Modern precision medicine focuses on identifying molecular signatures that distinguish diseased cells from healthy ones, such as overexpressed receptors or unique genetic mutations [2, 9]. Because 'Diseased cells' encompasses an extremely diverse range of cell types and pathologies, it lacks the specificity required for categorization as a single drug target. Instead, therapeutic strategies utilize targeted drug delivery systems to home in on these cells by recognizing specific molecular markers [5, 9]. Determining which molecular defects are actually responsible for the disease state is the primary step in identifying valid therapeutic targets [6, 8].

Other names
Pathological cellsAbnormal cellsMalfunctioning cellsSomatic diseased cells
02

Mechanism of action

Not applicable; 'Diseased cells' refers to a biological state or population of cells rather than a specific molecular target (e.g., a protein or receptor) that can be modulated by a drug.

03

Biological functions

Cellular homeostasisSignal transductionCell cycleApoptosisCell proliferation
04

Disease associations

CancerInflammationNeurodegenerative diseaseCardiovascular diseaseInfection
05

Safety considerations

Off-target toxicity to healthy cellsLack of therapeutic specificitySystemic adverse effectsImmune response against delivery vehicles
06

Biomarkers

Cell-surface antigensGenetic mutationsDifferential protein expression patternsAltered metabolic profiles

Beyond the preview

Go deeper on Diseased cells.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Diseased cells.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call